BIM
VTAE

Bogle Investment Management’s VITAE PHARMACEUTICALS INC COMMON STOCK VTAE Stock Holding History

Bogle Investment Management’s Portfolio VTAE Stock Details VTAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-14,285
Closed -$237K – 465
2014
Q4 		$237K Buy
+14,285
New +$209K 0.02% 325

Other funds holding VTAE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bogle Investment Management's VTAE Position: Q1 2015 in Review

Bogle Investment Management sold out of VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) in Q1 2015, closing a stake of 14,285 shares — an estimated $237K sold.

Bogle Investment Management first reported a position in VTAE in Q4 2014 and held it in 1 quarter. The position peaked at $237K in Q4 2014. 52 funds tracked by Wall St. Rank hold VTAE as of Q1 2015.

  • Bogle Investment Management reported no remaining VITAE PHARMACEUTICALS INC COMMON STOCK position as of Q1 2015 after selling out during the quarter.
  • Bogle Investment Management sold 14,285 VITAE PHARMACEUTICALS INC COMMON STOCK shares in Q1 2015, an estimated $237K.
  • Bogle Investment Management first reported a position in VITAE PHARMACEUTICALS INC COMMON STOCK in Q4 2014 and held it in 1 quarter.
  • Bogle Investment Management's VITAE PHARMACEUTICALS INC COMMON STOCK position peaked at $237K in Q4 2014.
  • 52 funds tracked by Wall St. Rank held VITAE PHARMACEUTICALS INC COMMON STOCK as of Q1 2015.

Based on Bogle Investment Management's 13F filing for Q1 2015, filed 15 May 2015.